MC1R is a potent regulator of PTEN after UV exposure in melanocytes

Molecular Cell

Volumn 51, Issue 4, 2013, Pages 409-422

  Cao, Juxiang ^a   Wan, Lixin ^b   Hacker, Elke ^c   Dai, Xiangpeng ^b   Lenna, Stefania ^a   Jimenez Cervantes, Celia ^d   Wang, Yongjun ^e   Leslie, NickR ^f   Xu, GeorgeX ^g   Widlund, HansR ^h   Ryu, Byungwoo ^a   Alani, RhodaM ^a   Dutton Regester, Ken ⁱ   Goding, ColinR ^j   Hayward, NicholasK ⁱ   Wei, Wenyi ^b   Cui, Rutao ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^d UNIVERSITY OF MURCIA   (Spain)

^e SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^f HERIOT WATT UNIVERSITY   (United Kingdom)

^g UNIVERSITY OF PENNSYLVANIA   (United States)

^h BRIGHAM AND WOMEN S HOSPITAL   (United States)

ⁱ QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^j UNIVERSITY OF OXFORD   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN; MELANOCORTIN 1 RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B;

ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; CELL FRACTIONATION; ENZYME ACTIVATION; GENETIC VARIABILITY; IN VITRO STUDY; MELANOCYTE; MELANOMA; MOUSE; NONHUMAN; PROTEIN DEGRADATION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; RADIATION EXPOSURE; SIGNAL TRANSDUCTION; ULTRAVIOLET RADIATION;

ALPHA-MSH; ANIMALS; BLOTTING, WESTERN; CELLS, CULTURED; GENE EXPRESSION REGULATION; HUMANS; IMMUNOENZYME TECHNIQUES; MELANOCYTES; MELANOMA, EXPERIMENTAL; MICE; MUTATION; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS B-RAF; PROTO-ONCOGENE PROTEINS C-AKT; PTEN PHOSPHOHYDROLASE; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTOR, MELANOCORTIN, TYPE 1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; SKIN PIGMENTATION; ULTRAVIOLET RAYS;

EID: 84882657764     PISSN: 10972765     EISSN: 10974164     Source Type: Journal    
DOI: 10.1016/j.molcel.2013.08.010     Document Type: Article

References (41)

1. Banito A., Rashid S.T., Acosta J.C., Li S., Pereira C.F., Geti I., Pinho S., Silva J.C., Azuara V., Walsh M., et al. Senescence impairs successful reprogramming to pluripotent stem cells. Genes Dev. 2009, 23:2134-2139.
2. Ben-Porath I., Weinberg R.A. The signals and pathways activating cellular senescence. Int. J. Biochem. Cell Biol. 2005, 37:961-976.
3. Braig M., Lee S., Loddenkemper C., Rudolph C., Peters A.H., Schlegelberger B., Stein H., Dörken B., Jenuwein T., Schmitt C.A. Oncogene-induced senescence as an initial barrier in lymphoma development. Nature 2005, 436:660-665.
4. Chen Z., Trotman L.C., Shaffer D., Lin H.K., Dotan Z.A., Niki M., Koutcher J.A., Scher H.I., Ludwig T., Gerald W., et al. Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature 2005, 436:725-730.
5. Cui R., Widlund H.R., Feige E., Lin J.Y., Wilensky D.L., Igras V.E., D'Orazio J., Fung C.Y., Schanbacher C.F., Granter S.R., Fisher D.E. Central role of p53 in the suntan response and pathologic hyperpigmentation. Cell 2007, 128:853-864.
6. D'Orazio J.A., Nobuhisa T., Cui R., Arya M., Spry M., Wakamatsu K., Igras V., Kunisada T., Granter S.R., Nishimura E.K., et al. Topical drug rescue strategy and skin protection based on the role of Mc1r in UV-induced tanning. Nature 2006, 443:340-344.
7. Dong L., Wen J., Pier E., Zhang X., Zhang B., Dong F., Ziegler N., Mysz M., Armenta R., Cui R. Melanocyte-stimulating hormone directly enhances UV-Induced DNA repair in keratinocytes by a xeroderma pigmentosum group A-dependent mechanism. Cancer Res. 2010, 70:3547-3556.
8. Dunham W.R., Klein S.B., Rhodes L.M., Marcelo C.L. Oleic acid and linoleic acid are the major determinants of changes in keratinocyte plasma membrane viscosity. J.Invest. Dermatol. 1996, 107:332-335.
9. García-Borrón J.C., Sánchez-Laorden B.L., Jiménez-Cervantes C. Melanocortin-1 receptor structure and functional regulation. Pigment Cell Res. 2005, 18:393-410.
10. Garraway L.A., Widlund H.R., Rubin M.A., Getz G., Berger A.J., Ramaswamy S., Beroukhim R., Milner D.A., Granter S.R., Du J., et al. Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma. Nature 2005, 436:117-122.
11. Goldstein A.M., Landi M.T., Tsang S., Fraser M.C., Munroe D.J., Tucker M.A. Association of MC1R variants and risk of melanoma in melanoma-prone families with CDKN2A mutations. Cancer Epidemiol. Biomarkers Prev. 2005, 14:2208-2212.
12. Ha L., Merlino G., Sviderskaya E.V. Melanomagenesis: overcoming the barrier of melanocyte senescence. Cell Cycle 2008, 7:1944-1948.
13. Halder R.M., Bridgeman-Shah S. Skin cancer in African Americans. Cancer 1995, 75(Suppl):667-673.
14. Hayward N. New developments in melanoma genetics. Curr. Oncol. Rep. 2000, 2:300-306.
15. Henri P., Beaumel S., Guezennec A., Poumès C., Stoebner P.E., Stasia M.J., Guesnet J., Martinez J., Meunier L. MC1R expression in HaCaT keratinocytes inhibits UVA-induced ROS production via NADPH oxidase- and cAMP-dependent mechanisms. J.Cell. Physiol. 2012, 227:2578-2585.
16. Hollander M.C., Blumenthal G.M., Dennis P.A. PTEN loss in the continuum of common cancers, rare syndromes and mouse models. Nat. Rev. Cancer 2011, 11:289-301.
17. Kinsler V.A., Abu-Amero S., Budd P., Jackson I.J., Ring S.M., Northstone K., Atherton D.J., Bulstrode N.W., Stanier P., Hennekam R.C., et al. Germline melanocortin-1-receptor genotype is associated with severity of cutaneous phenotype in congenital melanocytic nevi: a role for MC1R in human fetal development. J.Invest. Dermatol. 2012, 132:2026-2032.
18. Kunisada T., Lu S.Z., Yoshida H., Nishikawa S., Nishikawa S., Mizoguchi M., Hayashi S., Tyrrell L., Williams D.A., Wang X., Longley B.J. Murine cutaneous mastocytosis and epidermal melanocytosis induced by keratinocyte expression of transgenic stem cell factor. J.Exp. Med. 1998, 187:1565-1573.
19. Landi M.T., Bauer J., Pfeiffer R.M., Elder D.E., Hulley B., Minghetti P., Calista D., Kanetsky P.A., Pinkel D., Bastian B.C. MC1R germline variants confer risk for BRAF-mutant melanoma. Science 2006, 313:521-522.
20. Maddika S., Kavela S., Rani N., Palicharla V.R., Pokorny J.L., Sarkaria J.N., Chen J. WWP2 is an E3 ubiquitin ligase for PTEN. Nat. Cell Biol. 2011, 13:728-733.
21. Maehama T., Dixon J.E. The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J.Biol. Chem. 1998, 273:13375-13378.
22. Michaloglou C., Vredeveld L.C., Soengas M.S., Denoyelle C., Kuilman T., van der Horst C.M., Majoor D.M., Shay J.W., Mooi W.J., Peeper D.S. BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature 2005, 436:720-724.
23. Miller A.J., Mihm M.C. Melanoma. N.Engl. J. Med. 2006, 355:51-65.
24. Ming M., Feng L., Shea C.R., Soltani K., Zhao B., Han W., Smart R.C., Trempus C.S., He Y.Y. PTEN positively regulates UVB-induced DNA damage repair. Cancer Res. 2011, 71:5287-5295.
25. Mitra D., Luo X., Morgan A., Wang J., Hoang M.P., Lo J., Guerrero C.R., Lennerz J.K., Mihm M.C., Wargo J.A., et al. An ultraviolet-radiation-independent pathway to melanoma carcinogenesis in the red hair/fair skin background. Nature 2012, 491:449-453.
26. Nardella C., Chen Z., Salmena L., Carracedo A., Alimonti A., Egia A., Carver B., Gerald W., Cordon-Cardo C., Pandolfi P.P. Aberrant Rheb-mediated mTORC1 activation and Pten haploinsufficiency are cooperative oncogenic events. Genes Dev. 2008, 22:2172-2177.
27. Odriozola L., Singh G., Hoang T., Chan A.M. Regulation of PTEN activity by its carboxyl-terminal autoinhibitory domain. J.Biol. Chem. 2007, 282:23306-23315.
28. Peeper D.S. Oncogene-induced senescence and melanoma: where do we stand?. Pigment Cell Melanoma Res. 2011, 24:1107-1111.
29. Rabinovsky R., Pochanard P., McNear C., Brachmann S.M., Duke-Cohan J.S., Garraway L.A., Sellers W.R. p85 Associates with unphosphorylated PTEN and the PTEN-associated complex. Mol. Cell. Biol. 2009, 29:5377-5388.
30. Raimondi S., Sera F., Gandini S., Iodice S., Caini S., Maisonneuve P., Fargnoli M.C. MC1R variants, melanoma and red hair color phenotype: a meta-analysis. Int. J. Cancer 2008, 122:2753-2760.
31. Schiöth H.B., Phillips S.R., Rudzish R., Birch-Machin M.A., Wikberg J.E., Rees J.L. Loss of function mutations of the human melanocortin 1 receptor are common and are associated with red hair. Biochem. Biophys. Res. Commun. 1999, 260:488-491.
32. Sherr C.J., McCormick F. The RB and p53 pathways in cancer. Cancer Cell 2002, 2:103-112.
33. Song M.S., Salmena L., Pandolfi P.P. The functions and regulation of the PTEN tumour suppressor. Nat. Rev. Mol. Cell Biol. 2012, 13:283-296.
34. Tap W.D., Gong K.W., Dering J., Tseng Y., Ginther C., Pauletti G., Glaspy J.A., Essner R., Bollag G., Hirth P., et al. Pharmacodynamic characterization of the efficacy signals due to selective BRAF inhibition with PLX4032 in malignant melanoma. Neoplasia 2010, 12:637-649.
35. Thomas N.E., Kanetsky P.A., Edmiston S.N., Alexander A., Begg C.B., Groben P.A., Hao H., Busam K., Ollila D.W., Berwick M., Conway K. Relationship between germline MC1R variants and BRAF-mutant melanoma in a North Carolina population-based study. J.Invest. Dermatol. 2010, 130:1463-1465.
36. Trotman L.C., Wang X., Alimonti A., Chen Z., Teruya-Feldstein J., Yang H., Pavletich N.P., Carver B.S., Cordon-Cardo C., Erdjument-Bromage H., et al. Ubiquitination regulates PTEN nuclear import and tumor suppression. Cell 2007, 128:141-156.
37. Vredeveld L.C., Possik P.A., Smit M.A., Meissl K., Michaloglou C., Horlings H.M., Ajouaou A., Kortman P.C., Dankort D., McMahon M., et al. Abrogation of BRAFV600E-induced senescence by PI3K pathway activation contributes to melanomagenesis. Genes Dev. 2012, 26:1055-1069.
38. Wang X., Trotman L.C., Koppie T., Alimonti A., Chen Z., Gao Z., Wang J., Erdjument-Bromage H., Tempst P., Cordon-Cardo C., et al. NEDD4-1 is a proto-oncogenic ubiquitin ligase for PTEN. Cell 2007, 128:129-139.
39. Wu H., Goel V., Haluska F.G. PTEN signaling pathways in melanoma. Oncogene 2003, 22:3113-3122.
40. Young A.P., Schlisio S., Minamishima Y.A., Zhang Q., Li L., Grisanzio C., Signoretti S., Kaelin W.G. VHL loss actuates a HIF-independent senescence programme mediated by Rb and p400. Nat. Cell Biol. 2008, 10:361-369.
41. Zhang H., Cicchetti G., Onda H., Koon H.B., Asrican K., Bajraszewski N., Vazquez F., Carpenter C.L., Kwiatkowski D.J. Loss of Tsc1/Tsc2 activates mTOR and disrupts PI3K-Akt signaling through downregulation of PDGFR. J.Clin. Invest. 2003, 112:1223-1233.